Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Stimulants, Antipsychotic Drugs), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
Autism Spectrum Disorder Treatment Market Growth & Trends
The global autism spectrum disorder treatment market size is expected to reach USD 3.28 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% from 2023 to 2030. Many of the experimental autism spectrum disorder (ASD) drugs in the academic studies and pharma pipeline are assessing important theories about how the genetic fingerprint and brain contribute to the development of autism. Some of the pipeline drugs include AB-2004 & AB-2004 PTR by Axial Therapeutics, Inc., Zygel by Zynerba Pharmaceuticals, Inc., and INP105 (Olanzapine) by Impel Pharmaceuticals Inc.
In July 2022, Impel Pharmaceuticals Inc. initiated the first patient dose in phase 2a study evaluating INP-105 to treat acute agitation in adolescents with autism spectrum disorder (ASD). The company uses its Precision Olfactory Delivery (POD) technology to deliver medicine to the upper nasal part and increase the absorption of the drug, without the need for injection. Thus, technological advancement in drug delivery is anticipated to drive the market.
In May 2020, HARMAN International and F. Hoffmann-La Roche Ltd. entered into a global partnership to develop a digital therapeutic platform for individuals with ASD. Under this partnership, Harman and Samsung combined their extensive technology with F. Hoffmann-La Roche Ltd.’s leadership in neuroscience to develop innovative therapies for the treatment of ASD.
Rising awareness and funding for research and development of autism spectrum disorder are expected to positively contribute to the growth of the market. For instance, the Sapienza Università di Roma every year celebrates the 2nd of April as ‘World Autism Awareness Day’ with an aim to increase awareness about the disease and its treatment benefits among physicians and patients. Furthermore, in November 2022, the Defiance County Board of Developmental Disabilities/Good Samaritan School and the Andrew Jimenez Autism Fund received a donation of USD 1000 from Buckeye Roofing and Exteriors owner to support the efforts to raise awareness about ASD, subsequently creating an opportunity for the market growth.
Autism Spectrum Disorder Treatment Market Report Highlights
- By treatment type, the stimulants segment accounted for the largest share in 2022. This can be attributed to the availability of FDA-approved stimulants for the symptom management of disease in the market
- Based on application, the autistic disorder segment dominated the market in 2022 owing to the rising incidence of the disease. As per the 3 cohort studies, the incidence of ASD was found to be more than 3% of the population as of May 2021
- The hospital pharmacy segment held the second-largest share in 2022. This growth can be attributed to an increase in inpatient visits for the diagnosis and treatment of patients with disease
- North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about autism spectrum disorder treatment, the availability of drugs for treatment, and an increase in disease prevalence
- Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment Scope
- 1.1.2 Regional Scope
- 1.1.3 Estimates and Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation and Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach: Commodity Flow Approach
- 1.7 Research Assumptions
- 1.8 List of Secondary Sources
- 1.9 List of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
- Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Snapshot
- Chapter 3 Autism Spectrum Disorder Treatment: Market Variables, Trends, and Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Central Nervous System Therapeutics Market
- 3.2 Penetration and Growth Prospect Mapping
- 3.3 Regulatory Landscape
- 3.4 Market Dynamics
- 3.5 Market Driver Analysis
- 3.5.1 Increasing Prevalence of ASD
- 3.5.2 Increasing Awareness About ASD Among Physicians and Patients
- 3.5.3 Increasing Funding for ASD R&D
- 3.6 Market Restraint Analysis
- 3.6.1 Lack of Approved Drugs
- 3.6.2 Failures of Preclinical to Clinical Translation of Targeted Treatments
- 3.7 PESTEL Analysis
- 3.8 Industry Analysis—Porter’s Five Forces
- 3.9 Pipeline Analysis
- Chapter 4 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)
- 4.1 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
- 4.2 Antipsychotic Drugs
- 4.2.1 Antipsychotic Drugs Market, 2018 - 2030 (USD Million)
- 4.2.2 Selective Serotonin Reuptake Inhibitors
- 4.2.2.1 Selective Serotonin Reuptake Inhibitors Market, 2018 - 2030 (USD Million)
- 4.2.3 Stimulants
- 4.2.3.1 Stimulants Market, 2018 - 2030 (USD Million)
- 4.2.4 Sleep Medication
- 4.2.4.1 Sleep Medication Market, 2018 - 2030 (USD Million)
- 4.2.5 Others
- 4.2.5.1 Others Market, 2018 - 2030 (USD Million)
- Chapter 5 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 5.1 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
- 5.2 Autistic Disorder
- 5.2.1 Autistic Disorder Market, 2018 - 2030 (USD Million)
- 5.3 Asperger Syndrome
- 5.3.1 Asperger Syndrome Market, 2018 - 2030 (USD Million)
- 5.4 Pervasive Developmental Disorder
- 5.4.1 Pervasive Developmental Disorder Market, 2018 - 2030 (USD Million)
- 5.5 Others
- 5.5.1 Others Market, 2018 - 2030 (USD Million)
- Chapter 6 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
- 6.1 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
- 6.2 Hospital Pharmacy
- 6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
- 6.3 Retail Pharmacy
- 6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
- 6.4 Online Pharmacy
- 6.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
- Chapter 7 Europe Autism Spectrum Disorder Treatment Market: Regional Estimates and Trend Analysis, by Drug Class, Application, Route of Administration, & Distribution Channel
- 7.1 North America
- 7.1.1 SWOT Analysis:
- 7.1.1.1 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.1.2 U.S.
- 7.1.2.1 Country Dynamics
- 7.1.2.2 Target Disease Prevalence
- 7.1.2.3 Competitive Scenario
- 7.1.2.4 Regulatory Framework
- 7.1.2.5 Reimbursement Scenario
- 7.1.2.6 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.1.3 Canada
- 7.1.3.1 Country Dynamics
- 7.1.3.2 Target Disease Prevalence
- 7.1.3.3 Competitive Scenario
- 7.1.3.4 Regulatory Framework
- 7.1.3.5 Reimbursement Scenario
- 7.1.3.6 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2 Europe
- 7.2.1 SWOT Analysis:
- 7.2.1.1 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2 U.K.
- 7.2.2.1 Country Dynamics
- 7.2.2.2 Target Disease Prevalence
- 7.2.2.3 Competitive Scenario
- 7.2.2.4 Regulatory Framework
- 7.2.2.5 Reimbursement Scenario
- 7.2.2.6 Prescription and Dispensing Scenario
- 7.2.2.7 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3 Germany
- 7.2.3.1 Country Dynamics
- 7.2.3.2 Target Disease Prevalence
- 7.2.3.3 Competitive Scenario
- 7.2.3.4 Regulatory Framework
- 7.2.3.5 Reimbursement Scenario
- 7.2.3.6 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4 France
- 7.2.4.1 Country Dynamics
- 7.2.4.2 Target Disease Prevalence
- 7.2.4.3 Competitive Scenario
- 7.2.4.4 Regulatory Framework
- 7.2.4.5 Reimbursement Scenario
- 7.2.4.6 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.5 Italy
- 7.2.5.1 Country Dynamics
- 7.2.5.2 Target Disease Prevalence
- 7.2.5.3 Competitive Scenario
- 7.2.5.4 Regulatory Framework
- 7.2.5.5 Reimbursement Scenario
- 7.2.5.6 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.6 Spain
- 7.2.6.1 Country Dynamics
- 7.2.6.2 Target Disease Prevalence
- 7.2.6.3 Competitive Scenario
- 7.2.6.4 Regulatory Framework
- 7.2.6.5 Reimbursement Scenario
- 7.2.6.6 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.7 Denmark
- 7.2.7.1 Country Dynamics
- 7.2.7.2 Target Disease Prevalence
- 7.2.7.3 Competitive Scenario
- 7.2.7.4 Regulatory Framework
- 7.2.7.5 Reimbursement Scenario
- 7.2.7.6 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.8 Sweden
- 7.2.8.1 Country Dynamics
- 7.2.8.2 Target Disease Prevalence
- 7.2.8.3 Competitive Scenario
- 7.2.8.4 Regulatory Framework
- 7.2.8.5 Reimbursement Scenario
- 7.2.8.6 Sweden Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.9 Norway
- 7.2.9.1 Country Dynamics
- 7.2.9.2 Target Disease Prevalence
- 7.2.9.3 Competitive Scenario
- 7.2.9.4 Regulatory Framework
- 7.2.9.5 Reimbursement Scenario
- 7.2.9.6 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.11 Rest of Europe
- 7.2.11.1 Rest of Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Asia Pacific
- 7.3.1 SWOT Analysis:
- 7.3.1.1 Asia PacificAutism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2 Japan
- 7.3.2.1 Country Dynamics
- 7.3.2.2 Target Disease Prevalence
- 7.3.2.3 Competitive Scenario
- 7.3.2.4 Regulatory Framework
- 7.3.2.5 Reimbursement Scenario
- 7.3.2.6 Prescription and Dispensing Scenario
- 7.3.2.7 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3 China
- 7.3.3.1 Country Dynamics
- 7.3.3.2 Target Disease Prevalence
- 7.3.3.3 Competitive Scenario
- 7.3.3.4 Regulatory Framework
- 7.3.3.5 Reimbursement Scenario
- 7.3.3.6 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4 India
- 7.3.4.1 Country Dynamics
- 7.3.4.2 Target Disease Prevalence
- 7.3.4.3 Competitive Scenario
- 7.3.4.4 Regulatory Framework
- 7.3.4.5 Reimbursement Scenario
- 7.3.4.6 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5 Australia
- 7.3.5.1 Country Dynamics
- 7.3.5.2 Target Disease Prevalence
- 7.3.5.3 Competitive Scenario
- 7.3.5.4 Regulatory Framework
- 7.3.5.5 Reimbursement Scenario
- 7.3.5.6 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6 South Korea
- 7.3.6.1 Country Dynamics
- 7.3.6.2 Target Disease Prevalence
- 7.3.6.3 Competitive Scenario
- 7.3.6.4 Regulatory Framework
- 7.3.6.5 Reimbursement Scenario
- 7.3.6.6 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7 Thailand
- 7.3.7.1 Country Dynamics
- 7.3.7.2 Target Disease Prevalence
- 7.3.7.3 Competitive Scenario
- 7.3.7.4 Regulatory Framework
- 7.3.7.5 Reimbursement Scenario
- 7.3.7.6 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8 Rest of APAC
- 7.3.8.1 Rest of APAC Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Latin America
- 7.4.1 SWOT Analysis:
- 7.4.1.1 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2 Brazil
- 7.4.2.1 Country Dynamics
- 7.4.2.2 Target Disease Prevalence
- 7.4.2.3 Competitive Scenario
- 7.4.2.4 Regulatory Framework
- 7.4.2.5 Reimbursement Scenario
- 7.4.2.6 Prescription and Dispensing Scenario
- 7.4.2.7 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3 Mexico
- 7.4.3.1 Country Dynamics
- 7.4.3.2 Target Disease Prevalence
- 7.4.3.3 Competitive Scenario
- 7.4.3.4 Regulatory Framework
- 7.4.3.5 Reimbursement Scenario
- 7.4.3.6 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4 Argentina
- 7.4.4.1 Country Dynamics
- 7.4.4.2 Target Disease Prevalence
- 7.4.4.3 Competitive Scenario
- 7.4.4.4 Regulatory Framework
- 7.4.4.5 Reimbursement Scenario
- 7.4.4.6 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Middle East & Africa (MEA)
- 7.5.1 SWOT Analysis
- 7.5.1.1 MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2 South Africa
- 7.5.2.1 Country Dynamics
- 7.5.2.2 Target Disease Prevalence
- 7.5.2.3 Competitive Scenario
- 7.5.2.4 Regulatory Framework
- 7.5.2.5 Reimbursement Scenario
- 7.5.2.6 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Saudi Arabia
- 7.5.3.1 Country Dynamics
- 7.5.3.2 Target Disease Prevalence
- 7.5.3.3 Competitive Scenario
- 7.5.3.4 Regulatory Framework
- 7.5.3.5 Reimbursement Scenario
- 7.5.3.6 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4 UAE
- 7.5.4.1 Country Dynamics
- 7.5.4.2 Target Disease Prevalence
- 7.5.4.3 Competitive Scenario
- 7.5.4.4 Regulatory Framework
- 7.5.4.5 Reimbursement Scenario
- 7.5.4.6 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5 Kuwait
- 7.5.5.1 Country Dynamics
- 7.5.5.2 Target Disease Prevalence
- 7.5.5.3 Competitive Scenario
- 7.5.5.4 Regulatory Framework
- 7.5.5.5 Reimbursement Scenario
- 7.5.5.6 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6 Rest of MEA
- 7.5.6.1 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 8 Autism Spectrum Disorder Treatment Market: Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.1.1 New Product Launch
- 8.1.2 Merger and Acquisition
- 8.1.3 Licensing Agreements
- 8.1.4 Conferences and Campaigns
- 8.2 Company Categorization
- 8.2.1 Innovators
- 8.2.2 Market Leaders
- 8.3 Vendor Landscape
- 8.3.1 List of Key Distributors and Channel Partners
- 8.3.2 Key Customers
- 8.4 Public Companies
- 8.4.1 Key Company Market Share Analysis, 2022
- 8.4.2 Company Market Position Analysis
- 8.4.3 Heat Map Analysis
- 8.4.4 Competitive Dashboard Analysis
- 8.4.4.1 Market Differentiators
- 8.5 Private Companies
- 8.5.1 List of Key Emerging Companies
- 8.5.2 Regional Network Map
- 8.6 Company Profiles
- 8.6.1.Curemark LLC
- 8.6.1.1 Company Overview
- 8.6.1.2 Financial Performance
- 8.6.1.3 Product Benchmarking
- 8.6.1.4 Strategic Initiatives
- 8.6.2 Bristol - Myers Squibb Company
- 8.6.2.1 Company Overview
- 8.6.2.2 Financial Performance
- 8.6.2.3 Product Benchmarking
- 8.6.2.4 Strategic Initiatives
- 8.6.3 Merck & Co., Inc.
- 8.6.3.1 Company Overview
- 8.6.3.2 Financial Performance
- 8.6.3.3 Product Benchmarking
- 8.6.3.4 Strategic Initiatives
- 8.6.4 Novartis AG
- 8.6.4.1 Company Overview
- 8.6.4.2 Financial Performance
- 8.6.4.3 Product Benchmarking
- 8.6.4.4 Strategic Initiatives
- 8.6.5 Eli Lilly and Company
- 8.6.5.1 Company Overview
- 8.6.5.2 Financial Performance
- 8.6.5.3 Product Benchmarking
- 8.6.5.4 Strategic Initiatives
- 8.6.6 Pfizer Inc.
- 8.6.6.1 Company Overview
- 8.6.6.2 Financial Performance
- 8.6.6.3 Product Benchmarking
- 8.6.6.4 Strategic Initiatives
- 8.6.7 Johnson & Johnson Services, Inc.
- 8.6.7.1 Company Overview
- 8.6.7.2 Financial Performance
- 8.6.7.3 Product Benchmarking
- 8.6.7.4 Strategic Initiatives
- 8.6.8 Otsuka Pharmaceutical Co., Ltd.
- 8.6.8.1 Company Overview
- 8.6.8.2 Financial Performance
- 8.6.8.3 Product Benchmarking
- 8.6.8.4 Strategic Initiatives
- 8.6.9 Yamo Pharmaceuticals
- 8.6.8.1 Company Overview
- 8.6.9.2 Financial Performance
- 8.6.9.3 Product Benchmarking
- 8.6.9.4 Strategic Initiatives
- 8.6.10 F. Hoffmann - La Roche Ltd.
- 8.6.10.1 Company Overview
- 8.6.10.2 Product Benchmarking
- 8.6.10.3 Strategic Initiatives
- 8.6.11 Axial Therapeutics Inc.
- 8.6.11.1 Company Overview
- 8.6.11.2 Product Benchmarking
- 8.6.11.3 Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook